Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients
Conditions: End Stage Renal Disease; Peritoneal Dialysis Interventions: Drug: Spironolactone; Drug: Losartan Sponsor: Chiang Mai University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials